In response to the Food and Drug Administration's (FDA) recent action that authorizes an additional dose of COVID 19 vaccine for immuno-compromised individuals, CMS is assuring people with Medicare who qualify for an additional dose that they can receive it with no cost sharing. This is part of President Biden's commitment that patients have access to the necessary vaccinations to protect themselves from COVID-19.
Medicare would pay for administering an additional dose of COVID-19 vaccines consistent with the modified FDA emergency use authorization (EUA) that was announced on August 13th.
Comments